CIK 0000875045
- Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330112644
- Phone
- +1 617-679-2000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Head of Development sold 634 shares at $245.93 ($155,920)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Head of Development sold 110 shares at $248.00 ($27,280)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 170 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 6,000,000 shares at $0.50 ($3,000,000)
- 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 2,704 shares (to pay taxes)
- 4 Planned sale Head of Development sold 431 shares at $269.43 ($116,124)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Head of Global Product Strat. gave up 244 shares (to pay taxes)
Page 7 of 86 · 1,714 filings